X5RL Pharmaceutical IP Dilemma: Profit vs. Equitable Access, CSR, GSK and Insulin Producers (Discussion Example)
Model discussion paragraph on the X5RL scenario: whether patients’ inability to pay is a drug company’s problem, how to integrate CSR to profit from IP while providing equitable access, and lessons from GSK and insulin producers.